These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1320867)

  • 1. Influence of turkey herpesvirus vaccination on the B-haplotype effect on Marek's disease resistance in 15.B-congenic chickens.
    Bacon LD; Witter RL
    Avian Dis; 1992; 36(2):378-85. PubMed ID: 1320867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes.
    Bacon LD; Witter RL
    Avian Dis; 1993; 37(1):53-9. PubMed ID: 8383961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotype specificity of B-haplotype influence on the relative efficacy of Marek's disease vaccines.
    Bacon LD; Witter RL
    Avian Dis; 1994; 38(1):65-71. PubMed ID: 8002902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Marek's disease: a review.
    Purchase HG
    Cancer Res; 1976 Feb; 36(2 pt 2):696-700. PubMed ID: 766959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of vaccinal immunity against Marek's disease.
    Witter RL; Offenbecker L
    Avian Dis; 1978; 22(3):396-408. PubMed ID: 211999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turkey herpesvirus infection in chickens: induction of lymphoproliferative lesions and characterization of vaccinal immunity against Marek's disease.
    Witter RL; Sharma JM; Offenbecker L
    Avian Dis; 1976; 20(4):676-92. PubMed ID: 186008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
    Calnek BW; Schat KA; Peckham MC; Fabricant J
    Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of a Marek's disease transplantable tumor in inbred line 72 chickens homozygous at the major (B) histocompatibility locus.
    Stephens EA; Witter RL; Nazerian K; Sharma JM
    Avian Dis; 1980; 24(2):358-74. PubMed ID: 6254488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
    Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H
    Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell activity in chickens exposed to Marek's disease virus: inhibition of activity in susceptible chickens and enhancement of activity in resistant and vaccinated chickens.
    Sharma JM
    Avian Dis; 1981; 25(4):882-93. PubMed ID: 6279075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marek's disease vaccine breaks: differences in viremia of vaccinated chickens between those with and without Marek's disease.
    Cho BR
    Avian Dis; 1976; 20(3):496-503. PubMed ID: 183650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B haplotype influence on the relative efficacy of Marek's disease vaccines in commercial chickens.
    Bacon LD; Witter RL
    Poult Sci; 1994 Apr; 73(4):481-7. PubMed ID: 8202426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of vaccination with avirulent herpesvirus on subsequent infection of chickens with virulent Marek's disease herpesvirus.
    Spencer JL; Robertson A
    Am J Vet Res; 1975 Aug; 36(08):1235-9. PubMed ID: 168799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of serologically defined major histocompatibility complex haplotypes on Marek's disease resistance in commercially bred White Leghorn chickens.
    Blankert JJ; Albers GA; Briles WE; Vrielink-van Ginkel M; Groot AJ; te Winkel GP; Tilanus MG; van der Zijpp AJ
    Avian Dis; 1990; 34(4):818-23. PubMed ID: 2282011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of T-2 Toxin on Turkey Herpesvirus-Induced Vaccinal Immunity Against Marek's Disease.
    Kufuor-Mensah E; Reed WM; Sleight S; Pestka J; Fadly AM; Dunn JR
    Avian Dis; 2016 Mar; 60(1):56-62. PubMed ID: 26953944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
    Sharma JM; Witter RL
    Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turkey herpesvirus. VII. The evolution of Marek's disease in chickens vaccinated at one day of age and challenged at different periods of time after vaccination.
    Pătraşcu IV; Calnek BV; Smith M
    Virologie; 1988; 39(1):35-40. PubMed ID: 2837003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marek's disease tumors in chickens vaccinated with turkey herpesvirus vaccine.
    Eidson CS
    Dev Biol Stand; 1982; 52():437-46. PubMed ID: 7166202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
    Sharma JM; Graham CK
    Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.